J Christian Virchow,Oliver Pfaar,Marek Lommatzsch
J Christian Virchow
Remission is the goal of modern asthma treatment. Allergen immunotherapy (AIT) is an essential component in the armamentarium of personalized asthma therapy. Subcutaneous AIT (SCIT) or sublingual AIT (SLIT) offer the possibility to prevent ...
Marek Lommatzsch
Marek Lommatzsch
The development and approval of DMAADs ("disease-modifying anti-asthmatic drugs"), in particular inhaled steroids (alone or in combination with long-acting bronchodilators), biologics and modern allergen immunotherapies, has fundamentally c...
Role of FEF25-75 in characterizing outpatients with asthma in clinical practice [0.03%]
FEF25-75%在哮喘门诊患者特征描述中的作用
Giorgio Ciprandi,Irene Schiavetti
Giorgio Ciprandi
Background: Asthma is characterized by variable airflow limitation. FEF25-75 has been proposed as a reliable marker for bronchial obstruction, especially when FEV1 and FEV1/FVC are normal. ...
Magdalena Zemelka-Wiacek,Marek Jutel
Magdalena Zemelka-Wiacek
Although used for over 100 years, allergen immunotherapy (AIT) is still an indispensable tool in modern allergy managemen20t due to its potential to cure allergic diseases. Its current rapid development through the application of personaliz...
Allergen immunotherapy of insect venom allergy: Almost 100 years old, but steadily updated [0.03%]
昆虫毒液过敏的变应原免疫疗法：已有近百年历史，但不断更新进展
Wolfgang Pfützner
Wolfgang Pfützner
llergen immunotherapy (AIT) with Hymenoptera venom (HV) shows high efficiency treating insect venom allergy, covering an almost 100-year-long history. Untreated patients with HV allergy can develop serious, potentially lethal sting reaction...
DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy [0.03%]
2023年DGAKI和PEI对话：诊断与过敏原免疫治疗
Oliver Pfaar,Eckard Hamelmann,Christian Taube et al.
Oliver Pfaar et al.
A roundtable discussion on February 10, 2023 between the German Society for Allergology and Clinical Immunology (DGAKI) and the Paul-Ehrlich-Institut (PEI) aimed to discuss in detail current aspects of allergen immunotherapy (AIT), its regu...
Allergen-specific immunotherapy and evidence: A European regulatory perspective [0.03%]
变应原特异性免疫疗法和证据：欧洲监管机构的视角
Detlef Bartel,Andreas Bonertz,Diana Hartenstein et al.
Detlef Bartel et al.
Allergen immunotherapy (AIT) has been performed for 112 years. In this article we summarize regulatory standards and challenges based on scientific evidence on AIT. Most crucial and timely aspects concerning AIT are addressed from the regul...
AIT in pediatric allergology: Opportunities and difficulties on the home stretch of the Therapy Allergen Ordinance [0.03%]
儿科过敏学中的AIT：在《治疗性变应原条例》最后阶段的机会和困难
Christian Vogelberg,Michael Gerstlauer
Christian Vogelberg
Allergen immunotherapy (AIT) is the only causal therapy for allergic diseases and therefore particularly important. Allergen preparations have been classified as medicinal products since 1989 (Directive 89/342/EEC) and were taken over into ...
Management of allergic rhinitis improves clinical outcomes of difficult-to-treat tic disorders or attention-deficit/hyperactivity disorders [0.03%]
过敏性鼻炎的管理可改善难治性抽动障碍或注意缺陷多动障碍的临床结局
Rui-Li Yu,Jing Wang,Xue-Song Wang et al.
Rui-Li Yu et al.
Aims: This case series aimed to evaluate the effects of treatment for allergic rhinitis (AR) in AR-diagnosed children with previous diagnosis of tic disorders/attention-deficit/hyperactivity disorders (TD/ADHD) but unresp...
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-R [0.03%]
胡蜂属毒液过敏的诊断和治疗：德国变态反应学和临床免疫学协会(DGAKI)与职业及环境皮炎协会(ABD)，德国变态反应学家医学协会(AeDA)，德国皮肤病学协会(DDG)，德国耳鼻喉学会(DGP)联合制定的S2k指南
Franziska Ruëff,Andrea Bauer,Sven Becker et al.
Franziska Ruëff et al.
Hymenoptera venom (HV) is injected into the skin during a sting by Hymenoptera such as bees or wasps. Some components of HV are potential allergens and can cause large local and/or systemic allergic reactions (SAR) in sensitized individuals...